Canonical: https://ownershiptrace.com/13f/companies/920

# Who owns BridgeBio Pharma, Inc. (BBI)? Elite investor 13F holders

7 tracked elite investors reported holding BridgeBio Pharma, Inc as of 2026-06-30, including Viking Global Investors, D.E. Shaw, Renaissance Technologies LLC, Bridgewater Associates, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases. The company offers Attruby, a next-generation oral small molecule near-complete TTR stabilizer for the treatment of cardiomyopathy of wild-type or transthyretin-mediated amyloidosis (ATTR-CM); Fosdenopterin, an intravenous formulation of synthetic cyclic…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Viking Global Investors](https://ownershiptrace.com/13f/investors/81) | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 741017831.00 USD | 9949219.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1103804/0001103804-26-000006-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 270586362.00 USD | 3633007.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Principal | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 63817890.00 USD | 856846.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Bridgewater Associates](https://ownershiptrace.com/13f/investors/8) | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 33377691.00 USD | 448143.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1350694/0001350694-26-000003-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 5747622.00 USD | 77170.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |
| [Polen Capital Management](https://ownershiptrace.com/13f/investors/61) | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 298069.00 USD | 4002.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1034524/0001172661-26-003035-index.html) |
| [GAMCO](https://ownershiptrace.com/13f/investors/137) | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 535995.00 USD | 300000.000000 | Principal | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/807249/0001140361-26-032508-index.html) |
| [Ancora Advisors / Ancora Holdings](https://ownershiptrace.com/13f/investors/101) | BRIDGEBIO PHARMA INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1446114/0001446114-26-000012-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)